Please login or register first to view this content.
Pediatrics Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
First Treatment for Progeria Gets FDA Approval
Vimpat Approved for Primary Generalized Tonic-Clonic Seizures
Pulse Oximetry, Vital Signs May Predict Hospital LOS in Pediatric Asthma Exacerbations
Flare Size in Skin Prick Test May Predict Oral Food Challenge Outcomes
USPSTF Finds Evidence Lacking for Child HTN Screening
Room Temperature Stable Fosphenytoin Gets FDA Approval
Endari Label Updated With Benefit Statement, Instructions for Use
FDA Approves Rx-to-OTC Switch of Sklice for Head Lice Treatment
Dupilumab Reduces Severe Asthma Attacks in Pediatric Trial
Once-Weekly Somatrogon Reduces Treatment Burden in Children With GHD
FDA: More Data on Remestemcel-L for Graft Versus Host Disease Needed
Investigational Gene Therapy Fast Tracked for Duchenne Muscular Dystrophy
Alkindi Sprinkle Approved for Pediatric Adrenocortical Insufficiency
Simponi Aria Approved for Polyarticular JIA, Pediatric Psoriatic Arthritis
OTC Medicines Containing “Clean” Inactive Ingredients Launched
Xeljanz Approved for Active Polyarticular Course Juvenile Idiopathic Arthritis
Haegarda Approved for Pediatric Hereditary Angioedema
Kalydeco Approval Expanded to Include Younger Cystic Fibrosis Patients
